tm logo
DIAKONOS ONCOLOGY
Live/Pending
NOTICE OF ALLOWANCE - ISSUED

issued

on 03 Dec 2024

Last Applicant/ Owned by

1110 NASA Parkway, Ste. 108i

Houston

TX

77058

Serial Number

98253483 filed on 03rd Nov 2023

Registration Number

N/A

Correspondent Address

Andrea Shannon

Andrea Shannon

HOUSTON, TX 77010-3095

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

DIAKONOS ONCOLOGY

Providing medical research and scientific research information in the field of oncology; medical research in the field of oncology; research and development of immunotherapy drugs Pharmaceutical preparations for human use consisting of immunotherapy agents for the treatment and prevention of cancer; vaccine preparations

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Providing medical research and scientific research information in the field of oncology; medical research in the field of oncology; research and development of immunotherapy drugs


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Pharmaceutical preparations for human use consisting of immunotherapy agents for the treatment and prevention of cancer; vaccine preparations


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98253483

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
03rd Dec 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
22nd Oct 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22nd Oct 2024PUBLISHED FOR OPPOSITION
02th Oct 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17th Sep 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
17th Sep 2024APPROVED FOR PUB - PRINCIPAL REGISTER
17th Sep 2024TEAS/EMAIL CORRESPONDENCE ENTERED
17th Sep 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
17th Jun 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
17th Jun 2024NON-FINAL ACTION WRITTEN